You are here

  • Home
  • Archive
  • Volume 30, Issue 4
  • Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)

Article info

Article menu
Download PDFPDF
Original research
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)

Authors

  • Irena Rohr Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany PubMed articlesGoogle scholar articles
  • Sara Alavi Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany PubMed articlesGoogle scholar articles
  • Rolf Richter Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany PubMed articlesGoogle scholar articles
  • Maren Keller Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany PubMed articlesGoogle scholar articles
  • Radoslav Chekerov Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany PubMed articlesGoogle scholar articles
  • Gülten Oskay-Özcelik Private Practice, Private Practice for Gynecologic Oncology, Berlin, Germany PubMed articlesGoogle scholar articles
  • Michaela Heinrich Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany Alice Salomon University of Applied Science Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Cagatay Taskiran Department of Obsteterics and Gynecology, Division of Gynecologic Oncology On behalf of TRSGO: Turkish Society of Gynecologic Oncology, Koc University School of Medicine, Istanbul, Turkey PubMed articlesGoogle scholar articles
  • Florence Joly GINECO and Regional Centre Control Against Cancer Francois, Baclesse Caen, France PubMed articlesGoogle scholar articles
  • Regina Berger AGO-Austria and University Hospital for Gynaecology and Obstetrics, Medical University of Innsbruck, Innsbruck, Austria PubMed articlesGoogle scholar articles
  • Andreas du Bois Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group and Kliniken Essen Mitte, Kliniken Essen Mitte, Essen, Germany PubMed articlesGoogle scholar articles
  • Andreja Gornjec Gynecologic Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia PubMed articlesGoogle scholar articles
  • Ignace Vergote Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, Katholieke Universiteit Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Patriciu Achimas-Cadariu University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca, Institute of Oncology Prof Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania PubMed articlesGoogle scholar articles
  • Domenica Lorusso MITO and Fondazione Policlinico Universitario A Gemelli IRCCS, Rome and Fondazione IRCCS Istituto Nazionale Die Tumori, Milan, Italy PubMed articlesGoogle scholar articles
  • Johanna Maenpaa Department of Obstetrics and Gynecology, NSGO and University of Tampere and Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  • Jalid Sehouli Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Charite, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Irena Rohr, Gynaecology, Charite Universitatsmedizin Berlin, Berlin 10117, Germany; irena.rohr{at}charite.de
View Full Text

Citation

Rohr I, Alavi S, Richter R, et al
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)
International Journal of Gynecologic Cancer 2020;30:509-514.

Publication history

  • Received September 10, 2019
  • Revision received December 20, 2019
  • Accepted January 22, 2020
  • First published March 5, 2020.
Online issue publication 
April 09, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.